Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Zoetis Inc. (ZTS - Analyst Report), the former Animal Health business of Pfizer Inc. (PFE - Analyst Report), announced recently that it intends to expand its manufacturing facility in Lincoln, Neb. Zoetis aims to facilitate the production of high-quality, reliable drugs for veterinarians, livestock offerings and the animals under their care through this expansion.

Through this move, the company intends to fulfill its objective of being a world-class manufacturer of animal health products by ensuring constant supply of high- quality therapies for animals.

Zoetis stated that the early construction work has commenced and full fledged work for expanding the existing facility is expected to start shortly. The entire process involves a three-story expansion (19,000 square-feet) of the existing production facility. This will facilitate the transfer of products to Lincoln from a third-party manufacturer. The work is expected to be completed in 2014.

We remind investors that Zoetis started trading on the New York Stock Exchange from Feb 1, 2013. Last month, Pfizer gave up its entire stake in Zoetis. Pfizer had announced its plans to spin off its Animal Health business in Jun 2012.

Zoetis emphasizes on the discovery, development, manufacture and marketing of veterinary vaccines and medicines. The company focuses on farm as well as companion animals and has presence in more than 120 countries. The Animal Health segment of Pfizer had delivered sales of $4.3 billion in 2012, up 3% year over year.

Zoetis carries a Zacks Rank #3 (Hold). Companies such as Biogen Idec Inc. (BIIB - Analyst Report) and Jazz Pharmaceuticals Public Limited Company (JAZZ - Analyst Report) appear to be more attractive. Both stocks carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%